Moderna
MRNA
#1684
Rank
S$15.61 B
Marketcap
S$39.97
Share price
1.44%
Change (1 day)
-23.54%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2025 (TTM): -S$4.18 Billion

According to Moderna 's latest financial reports the company's current earnings are S$2.20 Billion. In 2024 the company made an earning of -S$4.63 Billion, an increase over its 2023 earnings that were of -S$5.05 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$4.18 Billion-9.78%
2024 -S$4.63 Billion-8.22%
2023 -S$5.05 Billion-140.65%
2022 S$12.40 B-27.81%
2021 S$17.17 B-1911.15%
2020 -S$0.95 Billion44.7%
2019 -S$0.66 Billion28.63%
2018 -S$0.51 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regulus Therapeutics
RGLS
-S$61.25 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$29.81 B-834.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-S$53.93 Million-98.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$0.16 B-104.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$21.20 B-622.07%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
S$0.18 B-104.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$41.83 B-1,130.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-S$0.16 Billion-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA